ABC News on MSN
FDA examines use of testosterone prescriptions for menopause
There is rising off-label use of testosterone among menopausal women.
Dr. Kudzai Dombo reveals the insurance denials and dosing guesswork women face seeking testosterone therapy as FDA regulators ...
By Mrinalika Roy Sept 15 (Reuters) - Women increasingly turning to testosterone therapy to manage menopause symptoms are ...
RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug Administration (FDA) has implemented significant labeling changes for ...
The FDA's request for public input ahead of the hearing drew hundreds of submissions, with many women describing enhanced ...
FDA’s 2026 testosterone replacement therapy label overhaul seeks to remove age-related restriction
Add Yahoo as a preferred source to see more of our stories on Google. Athletes running on the asphalt in the streets of Bourg les Valence in the Drome department in France. The FDA is rewriting the ...
The U.S. FDA is reviewing the use of testosterone in menopausal women to manage symptoms like low sexual desire. Despite off-label use, no FDA-approved therapy exists for women. Concerns over safety ...
By Siddhi Mahatole and Padmanabhan Ananthan Sept 17 (Reuters) - U.S. health regulators will review the scientific evidence on testosterone use in menopausal women on Thursday, including its benefits, ...
This article presents an evaluation of testosterone marketing practices around the period of the testosterone label warning by physician specialty and rural vs urban primary care service area. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results